August 27th 2025
FDA approves updated COVID-19 vaccines for 2025-2026 but limits pediatric access, restricting use to older and high-risk groups.
Are primary prevention strategies altering the course of the perfect storm?
February 23rd 2021As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?
FDA issues EUA for bamlanivimab and etesevimab to treat COVID-19
February 11th 2021The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) of monoclonal antibodies bamlanivimab and etesevimab to treat mild coronavirus disease 2019 (COVID-19) in both pediatric and adult patients.
Treating MIS-C with intravenous immunoglobulins and methylprednisolone to improve fever course
February 3rd 2021Does using methylprednisolone along with intravenous immunoglobulins improve fever outcomes for multisystem inflammatory syndrome in children (MIS-C) cases? A French investigation offers some answers.